OHSU News

This email notification is intended as a heads up to OHSU communicators. It is not shared with external subscribers.

Targeted ‘radioligand’ improves survival in advanced prostate cancer

Targeted ‘radioligand’ improves survival in advanced prostate cancer

Injected agent targets radiation to prostate cancer cells, sparing most normal tissues.